Nano-X Earns an Important FDA Clearance (What It Means for Investors)

Published: April 6, 2021, 4:12 p.m.

The FDA has cleared the single-source Nano.ARC machine, which will be used in tomosynthesis applications (checking for breast cancer). It\u2019s a big step for the company which takes away some risk for investors in the company. This is a major milestone for Nano-X but much work remains and there are still manufacturing and distribution hurdles to be cleared. We\u2019ll also be talking Nike and its efforts to go direct-to-consumer which has shut out some major retailers.

\n


\n


\n

Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year.

\n

Start your journey toward's financial independence: https://www.7investing.com/subscribe

\n

Stop by our website to level-up your investing education:  https://www.7investing.com

\n

Follow us on Social Media

\n

\u25ba https://www.facebook.com/7investing/

\n

\u25ba https://twitter.com/7investing

\n

\u25ba https://instagram.com/7investing